Drug Safety in Developing Countries

Drug Safety in Developing Countries
Author: Yaser Mohammed Al-Worafi
Publsiher: Academic Press
Total Pages: 320
Release: 2020-06-04
ISBN 10: 9780128198377
ISBN 13: 0128198370
Language: EN, FR, DE, ES & NL

Drug Safety in Developing Countries Book Review:

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues Describes current achievements of drug safety practice in developing countries Addresses the challenges of drug safety in developing countries Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety

Drug Safety in Developing Countries

Drug Safety in Developing Countries
Author: Yaser Mohammed Al-Worafi
Publsiher: Academic Press
Total Pages: 686
Release: 2020-06-03
ISBN 10: 0128204125
ISBN 13: 9780128204122
Language: EN, FR, DE, ES & NL

Drug Safety in Developing Countries Book Review:

Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues Describes current achievements of drug safety practice in developing countries Addresses the challenges of drug safety in developing countries Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety

Global Health Interventions for U S Food and Drug Safety

Global Health Interventions for U S  Food and Drug Safety
Author: Anonim
Publsiher: Unknown
Total Pages: 20
Release: 2009
ISBN 10: 1928374650XXX
ISBN 13: OCLC:497953909
Language: EN, FR, DE, ES & NL

Global Health Interventions for U S Food and Drug Safety Book Review:

Safety of Medicines with Respect to Drug Counterfeiting in Developing Countries

Safety of Medicines with Respect to Drug Counterfeiting in Developing Countries
Author: Ahmed Elmi
Publsiher: Unknown
Total Pages: 135
Release: 2013
ISBN 10: 1928374650XXX
ISBN 13: OCLC:870421544
Language: EN, FR, DE, ES & NL

Safety of Medicines with Respect to Drug Counterfeiting in Developing Countries Book Review:

Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad

Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad
Author: Institute of Medicine,Board on Health Sciences Policy,Board on Global Health,Committee on Strengthening Core Elements of Food and Drug Regulatory Systems in Developing Countries
Publsiher: National Academies Press
Total Pages: 366
Release: 2012-09-03
ISBN 10: 030922408X
ISBN 13: 9780309224086
Language: EN, FR, DE, ES & NL

Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad Book Review:

A very high portion of the seafood we eat comes from abroad, mainly from China and Southeast Asia, and most of the active ingredients in medicines we take originate in other countries. Many low- and middle-income countries have lower labor costs and fewer and less stringent environmental regulations than the United States, making them attractive places to produce food and chemical ingredients for export. Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad explains that the diversity and scale of imports makes it impractical for U.S. Food and Drug Administration (FDA) border inspections to be sufficient to ensure product purity and safety, and incidents such as American deaths due to adulterated heparin imported from China propelled the problem into public awareness. The Institute of Medicine Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries took up the vital task of helping the FDA to cope with the reality that so much of the food, drugs, biologics, and medical products consumed in the United States originate in countries with less-robust regulatory systems. Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad describes the ways the United States can help strengthen regulatory systems in low and middle income countries and promote cross-border partnerships - including government, industry, and academia - to foster regulatory science and build a core of regulatory professionals. This report also emphasizes an array of practical approaches to ensure sound regulatory practices in today's interconnected world.

Monitoring for Drug Safety

Monitoring for Drug Safety
Author: William Howard Wallace Inman
Publsiher: Unknown
Total Pages: 673
Release: 1980
ISBN 10: 1928374650XXX
ISBN 13: UOM:39015003225706
Language: EN, FR, DE, ES & NL

Monitoring for Drug Safety Book Review:

Patents and Pharmaceutical Drugs

Patents and Pharmaceutical Drugs
Author: Julio J. Nogués
Publsiher: World Bank Publications
Total Pages: 41
Release: 1990
ISBN 10: 1928374650XXX
ISBN 13: 9182736450XXX
Language: EN, FR, DE, ES & NL

Patents and Pharmaceutical Drugs Book Review:

Promoting Safety of Medicines for Children

Promoting Safety of Medicines for Children
Author: World Health Organization
Publsiher: World Health Organization
Total Pages: 59
Release: 2007
ISBN 10: 9241563435
ISBN 13: 9789241563437
Language: EN, FR, DE, ES & NL

Promoting Safety of Medicines for Children Book Review:

Monitoring the safety of medicine use in children is of paramount importance since, during the clinical development of medicines, only limited data on this aspect are generated through clinical trials. Use of medicines outside the specifications described in the license (e.g. in terms of formulation, indications, contraindications or age) constitutes off-label and off-license use and these are a major area of concern. These guidelines are intended to improve awareness of medicine safety issues among everyone who has an interest in the safety of medicines in children and to provide guidance on effective systems for monitoring medicine safety in the pediatric populations. This book will be of interest to all health care professionals, medicine regulatory authorities, pharmacovigilance centers, academia, the pharmaceutical industry and policy-makers. Systems for monitoring medicine safety are described in Annex 1. Pharmacovigilance methods and some examples of recent information on adverse reactions to marketed medicines are discussed in Annex 2.--Publisher's description.

Drug Surveillance

Drug Surveillance
Author: Zbigniew Bańkowski,John F. Dunne
Publsiher: World Health Organization
Total Pages: 198
Release: 1993-12-31
ISBN 10: 1928374650XXX
ISBN 13: UCAL:B4767456
Language: EN, FR, DE, ES & NL

Drug Surveillance Book Review:

Records the proceedings of an international conference convened to consider mechanisms for improving international cooperation in the surveillance of drug safety and the reporting of adverse reactions. Attended by close to 200 representatives of regulatory authorities and the pharmaceutical industry as well as clinical pharmacologists, the conference aimed to identify the strengths and weaknesses of existing mechanisms for international cooperation and to propose improvements for the future.

Social and Administrative Aspects of Pharmacy in Low and Middle Income Countries

Social and Administrative Aspects of Pharmacy in Low  and Middle Income Countries
Author: Mohamed Izham Mohamed Ibrahim,Albert Wertheimer,Zaheer-Ud-Din Babar
Publsiher: Academic Press
Total Pages: 484
Release: 2017-10-31
ISBN 10: 0128112298
ISBN 13: 9780128112298
Language: EN, FR, DE, ES & NL

Social and Administrative Aspects of Pharmacy in Low and Middle Income Countries Book Review:

Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions examines the particularities of low- and middle-income countries and offers solutions based on their needs, culture and available resources. Drawing from the firsthand experience of researchers and practitioners working in these countries, this book addresses the socio-behavioral aspects of pharmacy and health, pharmacoeconomics, pharmaceutical policy, supply management and marketing, pharmacoepidemiology and public health pharmacy specific to low- and middle-income countries. While some practices may be applied appropriately in disparate places, too often pharmacy practice in low- and middle-income countries is directly copied from successes in developed countries, despite the unique needs and challenges low- and middle-income countries face. Examines key issues and challenges of pharmacy practice and the pharmaceutical sector specific to low- and middle-income countries Compares pharmacy practice in developed and developing countries to highlight the unique challenges and opportunities of each Provides a blueprint for the future of pharmacy in low- and middle-income countries, including patient-centered care, evidence-based care and promoting the role of the pharmacist for primary health care in these settings

Countering the Problem of Falsified and Substandard Drugs

Countering the Problem of Falsified and Substandard Drugs
Author: Institute of Medicine,Board on Global Health,Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products
Publsiher: National Academies Press
Total Pages: 376
Release: 2013-06-20
ISBN 10: 0309269393
ISBN 13: 9780309269391
Language: EN, FR, DE, ES & NL

Countering the Problem of Falsified and Substandard Drugs Book Review:

The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

Drug Safety Amendments of 1976

Drug Safety Amendments of 1976
Author: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment
Publsiher: Unknown
Total Pages: 545
Release: 1976
ISBN 10: 1928374650XXX
ISBN 13: UOM:39015081219258
Language: EN, FR, DE, ES & NL

Drug Safety Amendments of 1976 Book Review:

Drug Labeling in Developing Countries

Drug Labeling in Developing Countries
Author: United States
Publsiher: Congress
Total Pages: 193
Release: 1993
ISBN 10: 1928374650XXX
ISBN 13: MINN:31951D00286669B
Language: EN, FR, DE, ES & NL

Drug Labeling in Developing Countries Book Review:

Assessment of Pharmacovigilance Approaches for Monitoring the Safety of Antimalarial Drugs in Pregnancy

Assessment of Pharmacovigilance Approaches for Monitoring the Safety of Antimalarial Drugs in Pregnancy
Author: Anonim
Publsiher: Unknown
Total Pages: 199
Release: 2014
ISBN 10: 9789036104081
ISBN 13: 9036104084
Language: EN, FR, DE, ES & NL

Assessment of Pharmacovigilance Approaches for Monitoring the Safety of Antimalarial Drugs in Pregnancy Book Review:

The Importance of Pharmacovigilance

The Importance of Pharmacovigilance
Author: World Health Organization
Publsiher: Unknown
Total Pages: 48
Release: 2002-01-01
ISBN 10: 9789241590150
ISBN 13: 9241590157
Language: EN, FR, DE, ES & NL

The Importance of Pharmacovigilance Book Review:

The purpose of this document is to present the case for the importance of pharmacovigilance, to record its growth and potential as a significant discipline within medical science, and to describe its impact on patient welfare and public health.

Industrial Guide to Chemical and Drug Safety

Industrial Guide to Chemical and Drug Safety
Author: T. S. S. Dikshith,Prakash V. Diwan
Publsiher: John Wiley & Sons
Total Pages: 664
Release: 2003-05-27
ISBN 10: 0471458775
ISBN 13: 9780471458777
Language: EN, FR, DE, ES & NL

Industrial Guide to Chemical and Drug Safety Book Review:

Exposure to a wide variety of chemicals and drugs has become common in industrial, laboratory, and even household environments. Fortunately, global understanding and consequently global safety standards regarding the management of toxic and hazardous substances are fast approaching uniformity. The methods of handling, use, transportation, storage, and disposal in particular are moving toward standardization. As these protocols involving chemicals and drugs continue to cross international borders, students and professionals need a reliable resource to ensure they observe appropriate safety standards. The Industrial Guide to Chemical and Drug Safety covers not only current standards, but also a wealth of information on toxins to help regulatory bodies develop new protocols. Written in an accessible narrative style, the Guide covers chemicals by key classes such as solvents, pesticides, and metals, and also by key industries such as drugs, food additives, plastics, cosmetics, detergents, and soaps. The book explains the beneficial and harmful aspects of a broad range of materials to which students, trainees, skilled workers, managers, and personnel associated with regulatory agencies are exposed, with the purpose of helping them avoid the illnesses associated with the misuse of chemicals and drugs. Chapters include: -Heavy Metals -Pesticides -Industrial Solvents -Industrial Gases and Fumes -Drugs -Target Organ Toxicity -Disposal of Hazardous Chemicals -Guidance to Students and Workers -Good Laboratory Practice

Practical Drug Safety from A to Z

Practical Drug Safety from A to Z
Author: Barton Cobert,Pierre Biron
Publsiher: Jones & Bartlett Publishers
Total Pages: 402
Release: 2009-10-06
ISBN 10: 0763745278
ISBN 13: 9780763745271
Language: EN, FR, DE, ES & NL

Practical Drug Safety from A to Z Book Review:

The Dictionary of Drug Safety and Pharmacovigilance is an alphabetical guide to drug safety monitoring (pharmacovigilance), covering literally, the

Cobert s Manual Of Drug Safety And Pharmacovigilance Third Edition

Cobert s Manual Of Drug Safety And Pharmacovigilance  Third Edition
Author: Cobert Barton,Gregory William,Thomas Jean-loup
Publsiher: World Scientific
Total Pages: 524
Release: 2019-04-10
ISBN 10: 9813279168
ISBN 13: 9789813279162
Language: EN, FR, DE, ES & NL

Cobert s Manual Of Drug Safety And Pharmacovigilance Third Edition Book Review:

Completely revised and updated, Cobert's Manual of Drug Safety and Pharmacovigilance, Third Edition, is a how-to manual for those working in the fields of drug safety, clinical research, pharmacology, regulatory affairs, risk management, quality/compliance, and in government and legal professions.This comprehensive and practical guide discusses the theory and the practicalities of drug safety (also known as pharmacovigilance), and provides essential information on drug safety and regulations in the United States, Europe Union, and more, including: recognizing, monitoring, reporting, and cataloging serious adverse drug reactions.Cobert's Manual of Drug Safety and Pharmacovigilance, Third Edition, teaches the daily practice of drug safety in industry, hospitals, the FDA and other health agencies — both in the United States and around the world — and provides critical information about what to do when confronted with a drug safety problem.

Drug Safety and Pricing

Drug Safety and Pricing
Author: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Publsiher: Unknown
Total Pages: 117
Release: 2000
ISBN 10: 1928374650XXX
ISBN 13: PSU:000047032026
Language: EN, FR, DE, ES & NL

Drug Safety and Pricing Book Review:

Improving Drug Safety A Joint Responsibility

Improving Drug Safety     A Joint Responsibility
Author: Rolf Dinkel,Bruno Horisberger,Kenneth W. Tolo
Publsiher: Springer Science & Business Media
Total Pages: 338
Release: 2013-03-07
ISBN 10: 3642612504
ISBN 13: 9783642612503
Language: EN, FR, DE, ES & NL

Improving Drug Safety A Joint Responsibility Book Review:

As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety? In April 1990, this question became the theme for a conference at Wolfsberg, Switzerland, near the shores of Lake Constance. Called an "international dialogue conference" by its organizers, the meeting brought together leaders from the pharmaceutical industry, regulatory authorities, academia, medicine, consumer organizations and the media. Opening addresses were given by representatives of the Council for International Organizations of Medical Sciences (CIOMS), the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), the Swiss International Pharmaceutical Agency, and the RAD-AR Consortium. This book documents the papers presented and discussions held at this conference, which took the topic of risks and benefits of drug therapy one step further to responsibility. It includes a rich menu of issues for those who care about the evaluation of drug therapy, the ethics behind it, the expectations of the patient, and the role of traditional and nontraditional drug safety communica tions. The ideas expressed here come from different parts of the world but relate to common drug safety problems, observations, and scientific assessments; they provide insights into innovative approaches, cautious changes, and desired actions. The papers in this volume are broadly divided into conceptual perspectives (ethics, how the knowledge about drug risks and benefits is generated and appraised, the expectations in drug safety) and operational perspectives (communication, discussion, and action).